{"database": "lobbying", "table": "lobbying_activities", "rows": [[3240806, "d846e581-f005-4215-828a-d318a6c3bcc4", "Q3", "THE LIVINGSTON GROUP, LLC", 49635, "INNOVATIVE VACCINE TECHNOLOGIES", 2024, "third_quarter", "MED", "FY2025 appropriations for the development of a synthetic vaccine", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2024-10-16T15:10:02-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3240806"], "units": {}, "query_ms": 9.648237028159201, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}